Flosequinan

CHEMBL1908307 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
239.3 g/mol
LogP
1.1
Phase
4

A vasodilator formerly investigated for the treatment of heart failure that works by relaxing blood vessels to reduce the workload on the heart. It was withdrawn from the market due to concerns about increased mortality with long-term use. Research into its mechanism contributed to the understanding of heart failure pharmacology.

分子量

239.2700 g/mol

LogP

1.10

TPSA

56.60 Ų

リピンスキーの五則

適合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cn1cc([S+](C)[O-])c(=O)c2ccc(F)cc21

InChI

InChI=1S/C11H10FNO2S/c1-13-6-10(16(2)15)11(14)8-4-3-7(12)5-9(8)13/h3-6H,1-2H3

Molecular Formula

C11H10FNO2S

HBD / HBA

- / 5

回転可能結合数

1

重原子数

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A vasodilator formerly investigated for the treatment of heart failure that works by relaxing blood vessels to reduce the workload on the heart. It was withdrawn from the market due to concerns about increased mortality with long-term use. Research into its mechanism contributed to the understanding of heart failure pharmacology.

Yes, Flosequinan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1908307. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4474062. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.